• Mashup Score: 0

    A meta-analysis of 10 randomized, clinical trials of bisphosphonates in postmenopausal women with osteoporosis found that the drugs prevent one nonvertebral fracture per 100 women after 1 year of use.

    Tweet Tweets with this article
    • It takes over 12 months of #bisphosphonate therapy to prevent 1 nonvertebral fracture per 100 postmenopausal women with #osteoporosis. https://t.co/0y3V2Mteiw https://t.co/Jxxn4QySu8

  • Mashup Score: 1

    A meta-analysis of 10 randomized, clinical trials of bisphosphonates in postmenopausal women with osteoporosis found that the drugs prevent one nonvertebral fracture per 100 women after 1 year of use.

    Tweet Tweets with this article
    • It takes over 12 months of #bisphosphonate therapy to prevent 1 nonvertebral fracture per 100 postmenopausal women with osteoporosis. https://t.co/zW2puDAYVH https://t.co/TG0W44dxUf

  • Mashup Score: 25

    Women with a history of ductal carcinoma in situ (DCIS) have an elevated risk of a subsequent invasive breast cancer, but there are few established potentially modifiable factors known to lower this risk. Bisphosphonates are a commonly used treatment for patients with osteoporosis and have been shown to lower risks of recurrence and mortality in patients with invasive breast cancer; however,…

    Tweet Tweets with this article
    • Women with a history of ductal carcinoma in situ #DCIS have a lower risk of subsequent invasive #BreastCancer if they use #bisphosphonate, study by Li et al shows, suggesting a potential #cancerprevention approach. https://t.co/5Ph1ezUuMh https://t.co/lX2SZTtkPA